SCHEMBL21754802

SCHEMBL21754802

CC1O[C@H](COC(=O)c2ccc(-c3ccccc3)cc2)[C@@H](OC(=O)c2ccc(-c3ccccc3)cc2)[C@@H]1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
USP2 O75604 1/20 0.44
POLB P06746 1/20 0.44
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 2/20 0.41
NPY1R P25929 1/20 0.41
NPY2R P49146 1/20 0.41
SCN1A P35498 1/20 0.40
SCN2A Q99250 1/20 0.40
SCN3A Q9NY46 1/20 0.40
SLC1A5 Q15758 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8389853 0.93 POLB (0.49) PTPN1MEN1KMT2AUSP2POLB
SCHEMBL25510429 0.93 POLB (0.49) PTPN1MEN1KMT2AUSP2POLB
SCHEMBL26291341 0.93 POLB (0.49) PTPN1MEN1KMT2AUSP2POLB
SCHEMBL16926957 0.93 POLB (0.49) PTPN1MEN1KMT2AUSP2POLB
SCHEMBL14208949 0.93 POLB (0.49) PTPN1MEN1KMT2AUSP2POLB
SCHEMBL14931047 0.93 POLB (0.49) PTPN1MEN1KMT2AUSP2POLB
SCHEMBL25509971 0.93 POLB (0.49) PTPN1MEN1KMT2AUSP2POLB
SCHEMBL16769112 0.87 PTPN1 (0.45) PTPN1MEN1KMT2AUSP2POLB
SCHEMBL21754792 0.87 HPGD (0.46) PTPN1MEN1KMT2AUSP2POLB
SCHEMBL16769113 0.86 PTPN1 (0.47) PTPN1MEN1KMT2AUSP2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10570112-B2 Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same FUJIFILM CORPORATION (JP) 2020-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570112-B2 Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same TYMS, TYMP, RRM2B PTPN1 4173/4885MEN1 2277/4885KMT2A 1034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.